Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trialValentina Guarneri, PierFranco Conte, Saverio Cinieri et al.|European Journal of Cancer|2021Cited by 13